Learn More
PURPOSE To evaluate potential detrimental effects of exemestane on bone and lipid metabolism. PATIENTS AND METHODS Postmenopausal women with early breast cancer were randomly assigned to exemestane(More)
Aromatase inhibitors improve relapse-free survival in early breast cancer, but there is concern about possible detrimental effects on bone mineral density (BMD) and plasma lipids. This paper presents(More)
  • 1